CELLPROTHERA

CellProthera is a medical biotech company founded in 2008 in Mulhouse (France). Its activity is currently focused on the development of a revolutionary therapeutic approach allowing the regeneration of myocardial tissue following acute myocardial infarct by injection of a cell graft containing autologous adult stem cells (ASC) sampled directly from the patient.... CellProthera is in clinical phase, currently conducting an international clinical trial phase I/IIB including 44 European patients and about to start a supplementary trial in Singapore.

Primary location: Mulhouse France